Thyronamine derivatives and analogs and methods of use thereof

Details Thyronamine derivatives and analogs and methods of use thereof Thyronamine derivatives and analogs and methods of use thereof

2008-01-22

2008-01-22

Davis, Brian (Department: 1621)

Organic compounds -- part of the class 532-570 series

Organic compounds

Amino nitrogen containing

C564S316000, C564S336000, C564S347000, C514S648000, C514S649000, C514S651000, C514S654000

Reexamination Certificate

active

07321065

ABSTRACT:
Thyronamine derivatives and analogs, methods of using such compounds, and pharmaceutical compositions containing them are disclosed. Methods of preparing such compounds are also disclosed.

REFERENCES:
patent: 4366241 (1982-12-01), Tom et al.
patent: 4376110 (1983-03-01), David et al.
patent: 4391904 (1983-07-01), Litman et al.
patent: 4517288 (1985-05-01), Giegel et al.
patent: 4634664 (1987-01-01), Oestberg
patent: 4634666 (1987-01-01), Engleman et al.
patent: 4837168 (1989-06-01), de Jaeger et al.
patent: 5225539 (1993-07-01), Winter
patent: 5530101 (1996-06-01), Queen et al.
patent: 5565332 (1996-10-01), Hoogenboom et al.
patent: 5585089 (1996-12-01), Queen et al.
patent: 5693761 (1997-12-01), Queen et al.
patent: 5693762 (1997-12-01), Queen et al.
patent: 5733743 (1998-03-01), Johnson et al.
patent: 5837242 (1998-11-01), Holliger et al.
patent: 5858657 (1999-01-01), Winter et al.
patent: 5871907 (1999-02-01), Winter et al.
patent: 5877218 (1999-03-01), Herzig et al.
patent: 5969108 (1999-10-01), McCafferty et al.
patent: 5994519 (1999-11-01), Osbourn et al.
patent: 6172197 (2001-01-01), McCafferty et al.
patent: 6180336 (2001-01-01), Osbourn et al.
patent: 11-302235 (1999-11-01), None
patent: WO 90/07861 (1990-07-01), None
patent: WO 90/14334 (1990-11-01), None
patent: WO 91/17271 (1991-11-01), None
patent: WO 92/01047 (1992-01-01), None
patent: WO 92/22653 (1992-12-01), None
patent: WO 98/27972 (1998-07-01), None
patent: WO 00/72811 (2000-12-01), None
patent: WO 01/56989 (2001-08-01), None
patent: WO 02/060375 (2002-08-01), None
patent: WO 03/002078 (2003-01-01), None
patent: WO 03/106380 (2003-12-01), None
patent: WO 2004/020415 (2004-03-01), None
patent: WO 05/000309 (2005-01-01), None
Database CAPLUS on STN, Acc. No. 1937:3475, Hambourger et al., J. Pharmacol. (1936), 58, p. 53-61 (abstract).
Database CAPLUS on STN, Acc. No. 1966:5238, Shu'Ayb et al., Annals of Surgery (1965), 162(4), p. 690-9, discussion p. 699-701 (abstract).
Biondi B. et al., “Effects of Subclinical Thyroid Dysfunction on the Heart,”Ann Intern Med., 2002, 137, 904-914.
Boissier, J.R. et al., “Differential Inotropic-Chronotropic Action of Thyronamine,”Eur. J. Pharmacol., 1973, 22, 141-149.
Borowsky, B. et al., “Trace amines: Identification of a family of mammalian G protein-coupled receptors,”Proc. Natl. Acad. Sci., 2001, 98(16), 8966-8971.
Bunzow, J.R. et al., “Amphetamine, 3,4-Methylenedioxymethamphetamine, Lysergic Acid Diethylamide, and Metabolites of the Catecholamine Neurotransmitters are Agonists of a Rat Trace Amine Receptor,”Mol. Pharmacol., 2001, 60, 1181-1188.
Buu-Hoi, N.P., “Some Biological Effects of Thyronamine,”Med. Pharmacol. Exp., 1966, 15, 17-23.
Buu-Hoi, N.P. et al., “Thyronamine, a New Substance with Long-acting Positive Inotropic Effect,”Pharmacology, 1969, 2, 281-287.
Cody, V. et al., “Molecular Structure and Biochemical Activity of 3,5,3′-Triiodothyronamine,”Endocrine Research, 1984, 10(2), 91-99.
Cote, P. et al., “Thyronamine, a new inotropic agent: its cardiovascular effects and mechanism of action,”Cardiovascular Res., 1974, 8, 721-730.
Dratman, M.B., “On the Mechanism if Action of Thyroxin, an Amino Acid Analog of Tyrosine,”J. Theor. Biol., 1974, 46, 255-270.
Falkenstein, E. et al., “Multiple Actions of Steroid Hormones-A Focus on Rapid, Nongenomic Effects,”Pharmacol. Rev., 2000, 52(4), 513-555.
Hamilton, M.A. et al., “Safety and Hemodynamic Effects of Intravenous Triiodothyronine in Advanced Congestive Heart Failure,”Am. J. Cardiol. 1998, 81, 443-447.
Han, S-Y. et al., “Synthesis of side chain-modified idothyronines,”Int. J. Peptide Protein Res., 1987, 30, 652-661.
Meyer, T., “Triiodothyronamine-A Beta-adrenergic Metabolite of Triiodothyronine?”Horm. Metabol. Res., 1983, 15, 602-606.
Petit, L. et al., “A Synthesis of Thyronamine and Its Lower Homolog,”J. Org. Chem., 1961, 26, 3832-3834.
Rozanov, C.B. et al., “Immunohistochemical Mapping of Brain Triiodothyronine Reveals Prominent Localization in Central Noradrenergic Systems,”Neuroscience, 1996, 74(3), 897-915.
Stöhr, R., “Synthese des Thyronamins,”Hoppe-Seyler Z. physiol. Chem., 1931, 201, 142.
Sun, Z.-Q. et al., “Effects of thyroid hormone on action potential and repolarizing currents in rat ventricular myocytes,”Am. J. Physiol. Endocrinol. Metab., 2000, 278, E302-E307.
Thibault, O., “Recherhes sur la nature de la <<thyroxine active>>. Renforcement immediate par la thyroxamine des effets de l'adrénaline sur divers muscles lisses,”C. R. Soc. Chim. Biol., 1951, 797-800.
Tomita, K. et al., “Synthesis and Biological Activity of Some Triiodinated Analogues of Thyroxine,”J. Biol. Chem, 1956, 219, 595-604.
Walker, J.D. et al., “The novel effects of 3,5,3′-triiodo-L-thyronine on myocyte contractile function and β-adrenergic responsivness in dilated cardiomyopathy,”J. Thorac. Cardiovasc. Surg., 1994, 108, 672-679.
Yen, P.M., “Physiological and Molecular Basis of Thyroid Hormone Action,”Physiol. Rev., 2001, 81(3), 1097-1142.
Akerstrom, B. et al., “Protein G: A Powerful Tool for Binding and Detection of Monoclonal and Polyclonal Antibodies,”J. Immunol., 1985, 135(4), 2589-2592.
Fingl, E. et al., “General Principles,”The Pharmacological Basis of Therapeutics, 1975, Goodman, L.S. et al. (eds.), Chapter 1, Fifth Edition, 1-46.
Huse, W.D. et al., “Generation of a Large Combinatorial Library of the Immunoglobulin Repertoire in Phage Lambda,”Science, 1989, 246, 1275-1281.
Köhler, G. et al., “Derivation of Specific Antibody-Producing Tissue Culture and Tumor Lines by Cell Fusion,”Eur. J. Immunol., 1976, 6, 511-519.
Köhler, G. et al., “Continuous Cultures of Fused Cells Secreting Antibody of Predefined Specificity,”Nature, 1975, 256, 495-497.
Kronval, G., “A Surface Component in Group A, C, and G Streptococci with Non-Immune Reactivity for Immunoglobulin G,”J. Immunol., 1973, 111(5), 1401-1406.
Monroe, D., “Liposome Immunoassay: A New Ultrasensitive Analytical Method,”Amer. Clin. Prod. Rev., 1986, 5, 34-41.
Nillne, E.A. et al., “Deficiencies in Pro-thyrotropin-releasing Hormone Processing and Abnormalities in Thermoregulation in Cpefat/fatMice,”J. Biol. Chem., 2002, 277(50), 48587-48595.
Östberg, L. et al., “Human x (Mouse x Human) Hybridomas Stably Producing Human Antibodies,”Hybridoma, 1983, 2(4), 361-367.
Queen, C. et al., “A Humanized Antibody that Binds to the Interleukin 2 Receptor,”Proc. Natl. Acad, Sci. USA, 1989, 86, 10029-10033.
Ribeiro, M.O. et al., “Thyroid hormone-sympathetic interaction and adaptive thermogenesis are thyroid hormone receptor isoform-specific,”J. Clin. Invest., 2001, 108(1), 97-105.
Ward , E.S. et al., “Binding Activities of a Repertoire of Single Immunoglobulin Variable Domains Secreted fromEscherichia coli,” Nature, 1989, 341, 544-546.
Barnes, J.H. et al., “Synthesis of throxine and related substances, XII, Preparation of simple analogs of thyroxine,”Journal of the Chemical Society, 1953, Database CA [online], Accession No. 1954:24942, abstract, 1 page.
Barton, D.H.R. et al., “The biosynthesis of Amaryllidaceae alkaloids,”Proc. Chem. Soc., 1961, Database CA [online], Accession No. 1961:137639, abstract, 1 page.
Bhakuni, D.S. et al., “Synthesis of (.+−.)-scoulerine, (.+−.)-coreximine, (.+−.)-tetrahydropalmatine and their monobromo and dibromo derivatives,”Indian Journal of Chemistry, Section B: Organic Chemistry Including Medicinal Chemistry, 1983, Database CA [online], Accession No. 1983:488435, 22B(1), abstract, 1 page.
Bompart, Jaques et al., “Synthesis of new .beta.-blocking analogs of bevantolol,”Annales oPharm

Affiliated with

Also associated with

Rating

Thyronamine derivatives and analogs and methods of use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Thyronamine derivatives and analogs and methods of use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thyronamine derivatives and analogs and methods of use thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2816044